Tyrosine Kinase

Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-  
A1821 Ki8751Target: VEGFRSummary: VEGFR-2 inhibitor,potent and selective -  
A1196 SGX-5231 CitationTarget: METSummary: MET inibitor, highly selective, ATP-competitive -  
A2168 Dovitinib (TKI-258, CHIR-258)2 CitationTarget: FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Multitargeted RTK inhibitor -  
A2838 OSI-930Summary: Inhibitor of Kit, KDR, Flt, CSF-1R, c-Raf and Lck -  
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: Selective IGF-1R/IR inhibitor -  
A3228 BAY 61-3606 dihydrochlorideSummary: Syk tyrosine kinase inhibitor -  
A3501 IRAK inhibitor 2Summary: IRAK inhibitor -  
A3836 SR3335Summary: RORα agonist,partial inverse and selective -  
A1778 Vatalanib (PTK787) 2HClTarget: VEGFRSummary: Tyrosine kinase receptor inhibitor -  
A1173 AG-18Summary: EGFR/PDGFR inhibitor 
